Glatiramer acetate

Grey

Brand Name(s):Copaxone

Indication:All licensed indications

Rationale:1

Considered:Apr-09

Review Date:Jul-20

Comments:
On the balance of their clinical and cost effectiveness neither beta
interferon nor glatiramer acetate is recommended for the treatment of
multiple sclerosis (MS) in the NHS in England and Wales.

NICE TA32
Beta interferon and glatiramer acetate for the treatment of multiple sclerosis
JAN 2002